共 50 条
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
被引:34
|作者:
Dziedzic, Arkadiusz
[1
]
Issa, Julien
[2
,3
]
Hussain, Salman
[4
]
Tanasiewicz, Marta
[1
]
Wojtyczka, Robert
[5
]
Kubina, Robert
[6
]
Konwinska, Marta Dyszkiewicz
[2
,7
]
Riad, Abanoub
[8
]
机构:
[1] Med Univ Silesiaia, Dept Conservat Dent Endodont, Katowice, Poland
[2] Poznan Univ Med Sci, Dept Diagnost, Poznan, Poland
[3] Poznan Univ Med Sci, Doctoral Sch, Poznan, Poland
[4] Masaryk Univ, Czech Natl Ctr Evidence Based Healthcare & Knowle, Cochrane Czech Republ, Czech EBHC JBI Ctr Excellence,Masaryk Univ GRADE, Brno, Czech Republic
[5] Med Univ Silesiaia, Dept Microbiol & Virol, Sosnowiec, Poland
[6] Med Univ Silesiaia, Dept Pathol, Sosnowiec, Poland
[7] Poznan Univ Med Sci, Dept Anat, Poznan, Poland
[8] Masaryk Univ, Fac Med, Dept Publ Hlth, Brno, Czech Republic
关键词:
cross-sectional studies;
COVID-19;
vaccines;
decision making;
healthcare professionals;
vaccination hesitancy;
Poland;
D O I:
10.3389/fpubh.2022.938067
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
引用
收藏
页数:14
相关论文